Skip to main content
Journal of Genetic Engineering and Biotechnology
Fig. 2 | Journal of Genetic Engineering and Biotechnology

Fig. 2

From: Molecular docking and identification of G-protein-coupled receptor 120 (GPR120) agonists as SARS COVID-19 MPro inhibitors

Fig. 2

a Flowchart for docking procedure to obtain binding score for docking a ligand. b Flowchart for to view and save the protein-ligand complex. c Structural similarity and drug like properties of docked GPR 120 agonists versus Rolapitant and Fluvastatin. d Toxicity prediction for compound 34 (ProTox-II - Prediction of TOXicity of chemicals (charite.de))

Back to article page